FABRY NEPHROPATHY: SWITCH FROM ENZYME REPLACEMENT THERAPY TO ORAL CHAPERONE MIGALASTAT
Back
Abstract Number
WCN23-0160
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
FABRY NEPHROPATHY: SWITCH FROM ENZYME REPLACEMENT THERAPY TO ORAL CHAPERONE MIGALASTAT
Co-authors
Perretta, F.J.(1)*;
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Fresenius Medical Care, Nephrology, Escobar, Argentina;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/da72b711e5c6028687f7c0949737bb1c.pdf
Audio File
if any